78 filings
Page 3 of 4
8-K
u7h8jqr9hi4ebk3y7kp
3 Feb 21
Regulation FD Disclosure
12:00am
8-K
2bxy7pmts
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K/A
sk6vvk1hv8 b0oq
4 Jan 21
Departure of Directors or Certain Officers
4:32pm
8-K
g8nd9e y3n5c
11 Dec 20
Departure of Directors or Certain Officers
4:01pm
8-K
stxs7mrkykk8d
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
6ep5wycth8
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
8-K
e7luaqs919mlsn0iism
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
9y29q
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
1785m9 51bf
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
2gzp1k0vk1wpwdkvrw
30 Mar 20
Departure of Directors or Certain Officers
5:20pm
8-K
sb4h9xfoz4gq0bt
2 Mar 20
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
4:51pm
8-K
wo0dcjcs6f75jek
26 Feb 20
Entry into a Material Definitive Agreement
4:08pm
8-K
0exf jtm8psi7g
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
gmwj063
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
6kdirg9u6qas1x0
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
epec8tzo7bwgqmq5 d5
1 Nov 19
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:22pm
8-K
lhy97 q8t
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
8-K
momqmq dz6i
15 Oct 19
Results of Operations and Financial Condition
4:52pm
8-K
p9da f331
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
8-K
1iq2i4
7 Aug 19
Other Events
9:07am